Why Is Jublia So Hard to Find? [Explained for 2026]

If you've tried to fill a Jublia prescription recently, you may have run into more roadblocks than you expected. Jublia (efinaconazole) is not experiencing a national FDA drug shortage — but that doesn't mean it's easy to get. For many patients, filling Jublia comes with a maze of insurance denials, sticker-shock pricing, and limited pharmacy access that makes it feel like finding a needle in a haystack.

Here's a breakdown of why Jublia can be so difficult to access in 2026 — and what your options are.

What Is Jublia, and Why Do Patients Need It?

Jublia is a prescription topical antifungal solution containing efinaconazole 10%. It is FDA-approved to treat onychomycosis — the medical term for toenail fungus — caused by the dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes. It's applied once daily for 48 weeks (about 11 months) directly to the affected toenail and surrounding skin using an integrated flow-through brush applicator.

Unlike oral antifungals, Jublia has minimal systemic absorption and no known significant drug interactions, making it a preferred option for patients who can't take oral medications. Dermatologists, podiatrists, and primary care providers all prescribe it regularly.

Is There a Jublia Shortage in 2026?

As of 2026, Jublia is not listed on the FDA's official drug shortage database. The medication is manufactured by Ortho Dermatologics (Bausch Health) and supply has remained stable. So why do so many patients struggle to fill it?

The difficulty isn't a shortage of the drug itself — it's a combination of cost, insurance access barriers, and limited pharmacy program availability. Each of these factors can make the medication effectively inaccessible even when it's technically available.

Reason #1: The Cost Is Extremely High Without Insurance

Without insurance coverage or a discount program, a single 4 mL bottle of Jublia costs roughly $923–$1,055 at retail. Since treatment lasts 48 weeks and may require multiple bottles depending on how many toenails are affected, the total out-of-pocket cost for a full course of treatment can easily exceed $10,000.

While GoodRx and SingleCare coupons can bring the price down to roughly $727–$741 per bottle, that's still several hundred dollars per month. For many patients, this effectively makes the drug "unavailable" even though pharmacies carry it.

Reason #2: Insurance Often Doesn't Cover Jublia

Insurance coverage for Jublia is inconsistent at best. Many commercial insurance plans place it on a high tier or exclude it from formulary entirely. Medicare Part D plans typically do not cover Jublia. Medicaid coverage varies widely by state.

Even when a plan does cover Jublia, it commonly requires prior authorization or step therapy — meaning your insurer wants you to try and fail on a cheaper alternative (like oral terbinafine or ciclopirox nail lacquer) before they'll approve Jublia. This process can add weeks of delay and paperwork before you ever get the drug.

Reason #3: The Manufacturer Savings Program Has Pharmacy Restrictions

Ortho Dermatologics offers the Rx Access Program, which can bring the cost down significantly for eligible patients. Commercially insured patients with coverage may pay as little as $0 per fill. Uninsured cash-pay patients can pay as little as $75 for a 4 mL bottle.

However, there's a catch: the Rx Access Program is only valid at Walgreens and participating independent pharmacies. It does not work at CVS, Rite Aid, Walmart, Costco, or most grocery store pharmacies. And patients on Medicare, Medicaid, or other government health programs are not eligible for the program at all.

Reason #4: No Widely Available Generic — Yet

While the FDA has approved generic versions of efinaconazole (from manufacturers including Teva and Umedica), commercial availability of generic efinaconazole remains limited in 2026. The primary Jublia patent is expected to expire in 2028, with broader generic competition projected around 2029–2030. Until then, most patients are essentially limited to the brand-name product with all its associated costs.

Reason #5: Long Treatment Duration Means Repeated Fills

Jublia treatment lasts 48 weeks — nearly a full year. Most patients need monthly refills. This means every barrier to access (insurance, cost, pharmacy availability) isn't a one-time problem — it's something you face up to 12 times over the course of treatment. Each fill is another opportunity for an insurance denial, a prior authorization battle, or a pharmacy that doesn't stock the medication.

What Can You Do If You Can't Fill Your Jublia Prescription?

Here are your best options if you're struggling to access Jublia:

Check the Rx Access Program: Visit OrthoRxAccess.com and see if you qualify for a reduced price at Walgreens or a participating independent pharmacy.

Use GoodRx or SingleCare: These discount cards can reduce the cash price to roughly $727–$741 per 4 mL bottle at many pharmacies.

Appeal your insurance denial: If your plan denied Jublia due to step therapy or prior auth, ask your prescriber to submit documentation of why alternatives didn't work or are inappropriate for you.

Apply for the Bausch Health Patient Assistance Program: Eligible uninsured patients with low income may be able to receive Jublia at no cost through the manufacturer's patient assistance program.

Ask about a 90-day supply: Some plans and mail-order pharmacies offer lower per-bottle costs when you fill 3 months at a time.

Talk to your doctor about alternatives: Oral terbinafine (generic Lamisil) is much cheaper and often more effective, though it requires liver monitoring. Generic ciclopirox nail lacquer costs as little as $12–$20/month.

How medfinder Can Help

Finding out which specific pharmacies near you have Jublia in stock — and which participate in the manufacturer savings program — can save hours of phone calls. medfinder calls pharmacies on your behalf to find which ones can fill your Jublia prescription. Instead of calling pharmacy after pharmacy yourself, you provide your medication and location and get the results texted directly to you. Learn more about how to find Jublia in stock near you

The Bottom Line

Jublia isn't hard to find because of a drug shortage — it's hard to access because of cost, insurance barriers, and pharmacy program restrictions. Understanding these obstacles is the first step toward navigating them. Whether you pursue the manufacturer savings program, a GoodRx coupon, a patient assistance program, or an alternative therapy, there are options available. Talk to your prescriber about which path makes the most sense for your situation.